CN Patent

CN109069518B — 睾酮制剂以及用其治疗的方法

Assigned to Medela Kara Pharmaceutical Co ltd · Expires 2022-10-11 · 4y expired

What this patent protects

本公开内容涉及用于使用水性经鼻施用来施用睾酮或睾酮衍生物的新的药物组合物。本公开内容还提供了治疗与恐惧和焦虑相关的疾病和障碍、性欲减退或性腺功能减退的方法。

USPTO Abstract

本公开内容涉及用于使用水性经鼻施用来施用睾酮或睾酮衍生物的新的药物组合物。本公开内容还提供了治疗与恐惧和焦虑相关的疾病和障碍、性欲减退或性腺功能减退的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109069518B
Jurisdiction
CN
Classification
—
Expires
2022-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Medela Kara Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.